Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.31 |
| ▸ | TP53 | P04637 | 3/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 4/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1536830 | 1.00 | THRB (0.37) | THRBALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL11792087 | 1.00 | THRB (0.37) | THRBALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL1536941 | 1.00 | THRB (0.37) | THRBALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL1516375 | 1.00 | THRB (0.37) | THRBALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL534358 | 1.00 | THRB (0.37) | THRBALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL1536946 | 1.00 | THRB (0.37) | THRBALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL1537075 | 1.00 | THRB (0.37) | THRBALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL535075 | 1.00 | THRB (0.37) | THRBALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL1536821 | 1.00 | THRB (0.37) | THRBALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL5087400 | 1.00 | THRB (0.37) | THRBALDH1A1TP53HIF1ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080419-A | Stabilizer for preparing polycaprolactone and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122091709-A | Composite solid electrolyte, preparation method thereof and secondary battery containing composite solid electrolyte | — | 2026-05-26 | — | — | CN | claimed |
| CN-117430746-B | Janus particle based on GMA monomer emulsion polymerization and preparation method and application thereof | 江苏大学 | 2026-05-19 | — | — | CN | claimed |
| CN-122006505-A | Durable superhydrophobic uniform pore separation membrane and preparation method and application thereof | 沧州市天津工业大学研究院 | 2026-05-12 | — | — | CN | claimed |
| CN-122011872-A | PVB resin-based anti-corrosion weather-resistant coating and preparation method thereof | 江西天城高新材料有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4735935-A2 | SURFACE ACTIVATED CHEMICAL VAPOR DEPOSITION AND USES THEREOF | Gvd Corporation (US) | 2026-05-06 | — | — | EP | claimed |
| EP-4735934-A2 | SURFACE ACTIVATED CHEMICAL VAPOR DEPOSITION AND USES THEREOF | Gvd Corporation (US) | 2026-05-06 | — | — | EP | claimed |
| EP-4735933-A2 | SURFACE ACTIVATED CHEMICAL VAPOR DEPOSITION AND USES THEREOF | Gvd Corporation (US) | 2026-05-06 | — | — | EP | claimed |
| EP-3573461-B1 | ANTIMICROBIAL, NON-THROMBOGENIC POLYMER COMPOSITIONS | LUBRIZOL ADVANCED MAT INC (US) | 2026-04-22 | — | — | EP | claimed |
| US-12528966-B2 | Coatings | P2I LTD (GB) | 2026-01-20 | — | — | US | claimed |
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | claimed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | claimed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | claimed |
| US-6136896-A | Graft copolymers containing polydiorganosiloxane and polybutylene grafts | DOW CORNING CORPORATION (US) | 2000-10-24 | — | — | US | claimed |
| EP-0425436-B1 | Reactive silicone and/or fluorine containing hydrophilic prepolymers and polymers thereof | CIBA GEIGY AG (CH) | 1996-12-27 | — | — | EP | claimed |
| US-5239026-A | Curable fluorinated acrylates, adhesion promoters; silane coupler | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-08-24 | — | — | US | claimed |
| US-5152287-A | Cross-linked fluorinated polymers for use in gas sensors | CORDIS CORPORATION (US) | 1992-10-06 | — | — | US | claimed |
| EP-0425436-A2 | Reactive silicone and/or fluorine containing hydrophilic prepolymers and polymers thereof | CIBA-GEIGY AG (CH) | 1991-05-02 | — | — | EP | claimed |
| US-5010141-A | Heat- or UV-curable acrylic resins; coatings; films; biocompatible, water-swelling, oxygen-permeable contact lenses | CIBA-GEIGY CORPORATION (US) | 1991-04-23 | — | — | US | claimed |
| US-4387203-A | COPOLYMER OF AN UNSATURATED NITRILE, CONJUGATED DIENE AND UNSATURATED FLUORINE COMPOUND GASOLINE RESISTANCE | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1983-06-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12528966-B2 | Coatings | C9, SDC1, CD59 | THRB 2283/4885ALDH1A1 1446/4885TP53 4726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.